VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MYO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MYOMyomo, Inc.
$0.88$34M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMYOCash Flow

Myomo, Inc. (MYO) Cash Flow Statement

12Y historyFree accessUpdated daily

Free cash flow remains deeply negative, evidenced by a $2.5M outflow in 2026Q1 and a total cash reserve that has dwindled to $11.4M from a peak of $24.4M in 2024Q4.

Income StatementBalance SheetCash FlowRatios

MYO Cash Flow Statement

Annual statement

MYO Cash Flow Statement

Myomo, Inc. (MYO) cash flow statement — 12-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Cash from Operations-6.59M-14.51M-3.29M-6.17M-10.23M-9.55M-9.03M-10.34M-9.61M-6.15M-3.2M-3.33M-2.55M
Operating CF Margin %--35.46%-10.11%-32.08%-65.79%-68.9%-119.11%-269.48%-393.04%-394.74%-290.29%-483.49%-278.9%
Operating CF Growth %-9.35%-341.09%46.7%39.68%-7.18%-5.7%12.66%-7.66%-56.11%-92.13%3.95%-30.92%-
Net Income-15.08M-15.57M-6.18M-8.15M-10.72M-10.37M-11.56M-10.71M-10.32M-12.1M-3.62M-3.73M-2.92M
Depreciation & Amortization2.3M1.98M776.97K517.68K542.63K335.96K108.67K95.12K69.68K11.41K7.73K5.31K6.16K
Stock-Based Compensation1.88M2.08M874.44K1.12M1.19M1.1M614.3K907.99K814.67K279.51K94.09K53.84K89.39K
Deferred Taxes0000000048.92K-56.67K000
Other Non-Cash Items-2.69M855.86K-17.37K48.31K204.34K-19.73K959.13K-81.92K-36.27K5.2M5.35K-28.06K234.25K
Working Capital Changes-30.28K-3.86M1.26M293.21K-1.45M-585.5K848.91K-550.01K-186.57K505.97K307.18K363.96K43.33K
Change in Receivables865.74K376.97K-1.56M-495.6K47.45K-1.05M-522.94K-42.03K-101.49K-182.53K1.14K115.99K-47.33K
Change in Inventory188.5K-662.68K-1.4M-384.78K-607.4K-118.22K-271.55K-213.56K-140.82K-161.07K120.59K16.28K-90.57K
Change in Payables-1.66M-2.9M4.69M1.79M-711.9K1.11M1.22M60.74K466.19K563.23K364.17K00
Cash from Investing-1.75M-7.06M259.98K-2.03M-310.79K-326.46K-45.75K-51.99K-126.87K-67K-1.86K-27.94K-3.53K
Capital Expenditures121.62K-1.74M-1.36M-145.82K-111.79K-326.46K-45.75K-51.99K-126.87K-67K-1.86K-27.94K-3.53K
CapEx % of Revenue0.27%4.26%4.18%0.76%0.72%2.36%0.6%1.35%5.19%4.3%0.17%4.05%0.39%
Acquisitions0000-199K00000000
Investments-------------
Other Investing-1.13M-1.59M00-199K000-126.87K0000
Cash from Financing7.14M11.43M20.93M9.71M376.86K13.17M16.78M8.32M3.34M18.38M2.96M1.98M3.44M
Debt Issued (Net)7.43M11.43M0000-1.96M2.79M0554.1K2.96M425K0
Equity Issued (Net)-243.71K020.37M9.72M376.86K13.17M18.55M5.6M017.7M000
Dividends Paid0000000000000
Share Repurchases-243.71K0000000-74.21K0000
Other Financing-40.44K0563.64K-8.12K00185.3K-73.38K3.34M129.61K2.87K1.56M3.44M
Net Change in Cash-1.45M-10.04M17.88M1.53M-10.18M3.28M7.7M-2.08M-6.4M12.16M-245.44K-1.38M885.62K
Free Cash Flow-7.67M-16.25M-4.65M-6.32M-10.35M-9.87M-9.08M-10.39M-9.73M-6.22M-3.2M-3.36M-2.55M
FCF Margin %-16.86%-39.71%-14.29%-32.84%-66.51%-71.26%-119.72%-270.83%-398.23%-399.03%-290.46%-487.54%-279.28%
FCF Growth %44.6%-249.54%26.41%38.92%-4.77%-8.76%12.65%-6.79%-56.47%-94.11%4.7%-31.83%-
FCF per Share-0.18-0.39-0.12-0.21-1.47-1.69-2.73-18.77-23.73-43.22-0.50-100.95-76.66
FCF Conversion (FCF/Net Income)0.51x0.93x0.53x0.76x0.95x0.92x0.78x0.97x0.93x0.51x0.89x0.74x0.72x
Interest Paid1.55M111.86K00000000000
Taxes Paid148.59K330.94K00000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and cash depletion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Remains Highly Volatile

According to reported financial data, the relationship between net income and operating cash flow is erratic, with the OCF/NI ratio swinging from -12.94 in 2024Q4 to 1.91 in 2025Q2, highlighting significant disconnects between accounting accruals and actual cash collection cycles for the MyoPro device.

The extreme variance in the OCF/NI ratio suggests that Myomo's cash generation is heavily influenced by the timing of insurance reimbursements rather than consistent operational performance. Investors should interpret this as a sign that reported net losses may not fully capture the underlying cash burn volatility inherent in the company's reimbursement-dependent business model.

Free Cash Flow Remains Deeply Negative

As indicated by quarterly cash flow statements, Myomo's free cash flow trajectory remains consistently negative, with a peak outflow of $10.1M in 2025Q2, underscoring the company's inability to self-fund its operations through its current transactional revenue model despite high gross margins on individual device sales.

The persistent FCF deficit suggests that the company is currently in a capital-intensive growth phase where the cost of patient acquisition and reimbursement navigation significantly outweighs the cash inflows from device sales. This trajectory warrants close monitoring, as the lack of a clear path to positive FCF suggests a continued reliance on external financing.

Working Capital Swings Drive Cash

Based on the provided cash flow statements, working capital changes have been a primary driver of quarterly cash fluctuations, ranging from a $5.0M outflow in 2025Q2 to a $2.8M inflow in 2024Q4, reflecting the lumpy nature of insurance authorization and subsequent payment cycles.

These swings indicate that Myomo's cash position is highly sensitive to the efficiency of its billing and collections department. The volatility in working capital suggests that management faces significant challenges in synchronizing the timing of device delivery with the receipt of cash from third-party payers.

Capital Intensity Rising With Scale

Data from recent filings shows that Myomo's capital expenditure as a percentage of revenue has trended upward, reaching 13.0% in 2025Q2, which suggests that the company is increasingly investing in infrastructure to support its custom manufacturing and clinical fitting requirements.

While the absolute dollar amounts remain relatively small, the rising capital intensity indicates that the business is becoming more asset-heavy as it attempts to scale its operations. This trend may indicate that future growth will require sustained capital investment, further pressuring the company's already strained cash reserves.

MYO — Frequently Asked Questions

Quick answers to the most common questions about buying MYO stock.

How much cash does Myomo, Inc. (MYO) generate from operations?

Myomo, Inc. (MYO) generated $-14.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Myomo, Inc.'s free cash flow?

Myomo, Inc. (MYO) reported negative free cash flow of $16.3M in 2025, indicating capital requirements exceeded cash from operations.

What is Myomo, Inc.'s capital expenditure (CapEx)?

Myomo, Inc. (MYO) spent $1.7M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.